Skip to main content
Overview
About
Our Story
Leadership
Corporate Sustainability
Careers
In the News
Strategy
Overview
Case Study 1
Case Study 2
Case Study 3
Operators
Overview
Capital Solutions
Portfolio
Investors
Overview
Company Information
Events & Presentations
Stock Information
Stock
Dividend
Analyst Coverage
Financials
Quarterly Results
Annual Reports
SEC Filings
News
Resources
Investor Email Alerts
Investor Contacts
Governance
Governance Documents
Committee Composition
Executive Leadership
Board
Corporate Sustainability
Annual Meeting and Proxy Materials
Contact
Sabra Health Logo
menu
close
Dividend
Stock
Dividend
Analyst Coverage
Dividend History
Dividend Tax Treatment
2025 Dividend Tax Treatment
2024 Dividend Tax Treatment
2023 Dividend Tax Treatment
2022 Dividend Tax Treatment
2021 Dividend Tax Treatment
2020 Dividend Tax Treatment
2019 Dividend Tax Treatment
2018 Dividend Tax Treatment
2017 Dividend Tax Treatment
2016 Dividend Tax Treatment
2015 Dividend Tax Treatment
2014 Dividend Tax Treatment
2013 Dividend Tax Treatment
2012 Dividend Tax Treatment
2011 Dividend Tax Treatment
IRS Form 8937
2025 IRS Form 8937
2024 IRS Form 8937
2023 IRS Form 8937
2022 IRS Form 8937
2021 IRS Form 8937
2020 IRS Form 8937
2019 IRS Form 8937
CCP Merger Consideration IRS Form 8937
CCP 2017 IRS Form 8937
2017 IRS Form 8937
2016 IRS Form 8937
2015 IRS Form 8937
2014 IRS Form 8937
2013 IRS Form 8937
2012 IRS Form 8937
2011 IRS Form 8937
Disclaimer
All distributions will be made by us at the discretion of our board of directors and will depend on our financial position, results of operations, cash flows, capital requirements, debt covenants (which include limits on distributions by us), applicable law, and other factors as our board of directors deem relevant.
Current Dividend Yield
is the most recent dividend annualized and expressed as a percent of the most recent closing price at which the stock last traded.
* On August 2, 2017, our Board of Directors declared a prorated quarterly cash dividend of approximately $0.36 per share of common stock, which is based on a full quarter dividend of $0.43 per share and prorated based on the period from June 1, 2017 through August 16, 2017, which is the last day prior to the merger closing date. Dividend will be paid on or promptly following August 18, 2017, to common stockholders of record as of the close of business on August 16. Difference between the prorated dividend and a full quarter dividend of $0.43 per share will be added to our next quarterly dividend.